News
2008
July 21 – 25
Latest Advances in Drug Discovery Design & Planning Methods: Virtual screening, structure-based drug design, lead optimization and predictive toxicology supporting decision making in drug discovery.
Medical Sciences Teaching Center, Oxford University, Oxford UK
On Friday July 25, 2008 9:00 – 10:00 a.m. Dr. Bill W. Massey of LITMUS Molecular Design, LLC, will be presenting "An In Silico Approach to Rational Antipsychotic Drug Design using Spectral Data Activity Relationships".
19 May
Spectral Modeling™ technology substantiated through creation of antipsychotic bank of drug candidates
March 25 – 28
Cambridge Healthtech Institute’s 15th International Molecular Medicine Tri-Conference
Moscone North Convention Center, San Francisco, California
March 26, 2008 3:40 p.m. Dr. Dan Buzatu will be presenting "SDAR: Spectrometric Data Activity Relationship Modeling".
March 26, 2008 3:55 p.m. Dr. Jon Wilkes will be presenting Modeling and Assaaying Dioxin-Like Biological Effects for Both Dioxin-Like and Certain Non-Dioxin-Like Compounds".
March 26-27, 2008 Neil Mitchell will present a poster entitled ""An In Silico Approach to Rational Antipsychotic Drug Design".
Link to "An In Silico Approach to Rational Antipsychotic Drug Design" Poster
2007
01 December
LITMUS Molecular Design Announces the Addition of Dr. Herbert Y. Meltzer to Scientific Advisory Board
03 July
Appointment of LITMUS Molecular Design President
LITMUS LLC today announces that Dr. Bill W. Massey has been appointed as President of its wholly owned subsidiary, LITMUS Molecular Design ("LMD").